Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients - Canziani, L M; Trovati, S; Brunetta, E (J Autoimmun, 2020)
et al.